Henry Schein stock reflects raised 2026 guidance at USD 86.37

Henry Schein stock was last at USD 86.37 on Nasdaq on September 25, 2026, after the healthcare distributor raised its fiscal 2026 outlook. The latest market view combines a USD 9.8 billion capitalization with second-quarter growth that outpaced the companys earlier sales expectations.

Guidance moves higher

According to Yahoo Finance in the August 4, 2026 earnings call, Henry Schein lifted its fiscal 2026 sales growth guidance to 4.5%-5.5% from 3%-5%. The company also raised adjusted diluted EPS guidance to USD 5.29-5.39 from USD 5.23-5.37.

The guidance change followed second-quarter sales of USD 3.46 billion, up 6.7 percent from the prior-year quarter. Adjusted EPS reached USD 1.27, a 15.5 percent year-over-year increase, while internal local-currency sales growth was 4.6 percent, according to Zacks.

Analysts see further upside

MarketBeat reported on September 28, 2026, that fifteen research firms had a consensus rating of Moderate Buy, with nine buy ratings, five holds and one sell rating. Their average 12 month price target was USD 92.93, which stands USD 6.56 above the September 25 price.

That target spread gives the market a concrete test for the guidance raise. The stock remains USD 5.81 below its 52-week high of USD 92.18 and USD 24.42 above its 52-week low of USD 61.95, placing the latest price closer to the yearly high than the yearly low.

Credit capacity supports expansion

A separate September 21, 2026 financing update expanded Henry Schein's revolving credit commitments from USD 1.0 billion to USD 1.25 billion and extended the facility to September 19, 2031, as Yahoo Finance reported on September 27, 2026. The additional capacity is intended for working capital, capital expenditures, share repurchases, refinancing and potential acquisitions.

For investors, the key operating question is whether higher sales growth can translate into sustained earnings expansion after foreign exchange effects and restructuring costs. Henry Schein also generated USD 242 million in operating cash flow in the second quarter, giving the efficiency program a measurable funding base.

Stock stays below yearly high

Henry Schein stock was last at USD 86.37 on Nasdaq on September 25, 2026, with a daily gain of 0.98 percent, a session range of USD 85.43-86.57 and volume of 1,202,226 shares.